```json
{
"ranked_hypotheses": [
{
"rank": 1,
"title": "GLT-1 Dysfunction Triggers Neuronal Glucose Hypometabolism via Excitotoxic Cascade",
"mechanism": "Astrocyte GLT-1 internalization reduces glutamate clearance, causing NMDA-mediated calcium overload that depletes neuronal ATP and impairs glucose utilization, ultimately triggering compensatory glycogenolysis and metabolic reserve exhaustion.",
"target_gene": "SLC1A2",
"confidence_score": 0.7,
"novelty_score": 0.5,
"feasibility_score": 0.55,
"impact_score": 0.85,
"composite_score": 0.67,
"testable_prediction": "Measure neuronal GLUT3 membrane localization and ATP levels in cortical slices from GLT-1 conditional knockout mice during excitotoxic challenge using live-cell imaging.",
"skeptic_concern": "The direct glutamate-to-GLUT3 inhibition link lacks evidence; NMDA-mediated excitotoxicity must be invoked as the intermediate mechanism."
},
{
"rank": 2,
"title": "Astrocyte-Neuron Lactate Shuttle Disruption as Metabolic Coupling Failure",
"mechanism": "Impaired astrocyte glycolysis reduces lactate production and monocarboxylate transporter function, starving neurons of alternative fuel during glucose deficit, exacerbating neurodegeneration.",
"target_gene": "SLC16A1",
"confidence_score": 0.55,
"novelty_score": 0.7,
"feasibility_score": 0.4,
"impact_score": 0.75,
"composite_score": 0.625,
"testable_prediction": "Perform isotope-tracing metabolomics in co-cultures to compare lactate flux from astrocytes to neurons under GLT-1 inhibition versus control conditions.",
"skeptic_concern": "MCT expression and function in human brain tissue is difficult to measure reliably, limiting translational validation."
},
{
"rank": 3,
"title": "Astrocyte Metabolic Inflammation Drives Neurodegenerative Metabolic Dysregulation",
"mechanism": "Disease-associated astrocytes adopt inflammatory phenotypes that shift metabolic programs from supportive lactate production and glycogen storage toward pro-inflammatory cytokine release, creating a toxic neuronal microenvironment.",
"target_gene": "GFAP",
"confidence_score": 0.5,
"novelty_score": 0.65,
"feasibility_score": 0.45,
"impact_score": 0.8,
"composite_score": 0.615,
"testable_prediction": "Characterize metabolic gene expression and cytokine secretion profiles in astrocytes derived from AD patient iPSCs versus age-matched controls.",
"skeptic_concern": "Causality versus correlation remains unresolved; inflammatory astrocytes may be secondary to rather than drivers of neuronal damage."
}
],
"consensus_points": [
"GLT-1 (SLC1A2) protein expression is reliably reduced 40-60% in AD patient cortex, representing the strongest established evidence.",
"Astrocyte metabolic dysfunction contributes to neuronal energy deficit in neurodegeneration, though the precise mechanistic pathway remains debated.",
"Translational targeting of astrocyte-neuron metabolic crosstalk requires validated biomarkers to identify suitable patient populations for clinical trials."
],
"dissent_points": [
"Theorist proposes direct glutamate inhibition of GLUT3, while Skeptic requires NMDA-mediated excitotoxicity as an intermediate; this mechanistic step is unresolved.",
"Expert prioritizes amyloid-centric therapeutic landscape and regulatory realities, whereas mechanistic hypotheses may face clinical development barriers within 5-8 year window."
],
"debate_summary": "GLT-1 dysfunction is well-supported by human AD data but requires mechanistic clarification on how extracellular glutamate accumulation triggers neuronal glucose deficit beyond direct GLUT3 inhibition. Alternative metabolic coupling pathways including the astrocyte-neuron lactate shuttle and inflammatory astrocyte reprogramming represent emerging targets with high translational potential but lesser direct human evidence. The field requires integrative models linking astrocyte metabolic failure to downstream neuronal energy crisis while accounting for excitotoxic, inflammatory, and compensatory mechanisms."
}
```